Robert Barrow - 16 Aug 2022 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MNMD
Reported as of: 16 Aug 2022
Net transaction value: -$13,838
SEC form: 4
Accepted by SEC: 17 Aug 2022, 18:36:48 UTC
Prior SEC filing: 26 Jul 2022
Next SEC filing: 01 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Carrie Liao, Attorney-in-Fact

Key filing fact

Robert Barrow filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 17 Aug 2022.

Key facts

This page summarizes Robert Barrow's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 18:36.

Change

Previous filing in this sequence was filed on 26 Jul 2022.
Current net transaction value: -$13,838.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MNMD transaction

Common Shares

Sale

Transaction value: $13,838
Shares: -20,350
Change %: -0.52%
Price: $0.6800^*
Shares after: 3,860,438
Date: 16 Aug 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Common Shares sold to satisfy withholding tax obligations upon the delivery of Common Shares for restricted stock units that vested on August 15, 2022 pursuant to sell-to-cover elections.

Footnote F2

The Common Shares were sold in one transaction at a price of $0.87 CAD Dollars. This represents the price in United States Dollars using the conversion rate on August 16, 2022.